{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:30:36Z","timestamp":1778542236549,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH099012"],"award-info":[{"award-number":["R01MH099012"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["5T32 DA07233"],"award-info":[{"award-number":["5T32 DA07233"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA041501"],"award-info":[{"award-number":["R01DA041501"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA035330"],"award-info":[{"award-number":["K01DA035330"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA041298"],"award-info":[{"award-number":["R01DA041298"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jsat.2019.10.001","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T23:06:36Z","timestamp":1574377596000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Factors associated with benzodiazepine prescribing in community mental health settings"],"prefix":"10.1016","volume":"109","author":[{"given":"Lauren","family":"Jessell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Stanhope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer I.","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Mateu-Gelabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2019.10.001_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2018.7399","article-title":"Patterns in outpatient benzodiazepine prescribing in the United States","volume":"2","author":"Agarwal","year":"2019","journal-title":"JAMA Network Open"},{"issue":"11","key":"10.1016\/j.jsat.2019.10.001_bb0010","first-page":"2227","article-title":"Updated beers criteria for potentially inappropriate medication use in older adults","volume":"63","author":"American Geriatrics Society","year":"2015","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1016\/j.jsat.2019.10.001_bb0015","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"issue":"10","key":"10.1016\/j.jsat.2019.10.001_bb0025","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1176\/appi.ps.54.10.1395","article-title":"Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders","volume":"54","author":"Brunette","year":"2003","journal-title":"Psychiatric Services"},{"issue":"11","key":"10.1016\/j.jsat.2019.10.001_bb9005","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s11606-013-2441-1","article-title":"Physicians and implicit bias: how doctors may unwittingly perpetuate health care disparities","volume":"28","author":"Chapman","year":"2013","journal-title":"Journal of general internal medicine"},{"key":"10.1016\/j.jsat.2019.10.001_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2018.02.011","article-title":"Examining racial\/ethnic differences in patterns of benzodiazepine prescription and misuse","volume":"187","author":"Cook","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.jsat.2019.10.001_bb9010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1176\/ps.2009.60.8.1007","article-title":"Shared decision making is an ethical imperative","volume":"60","author":"Drake","year":"2009","journal-title":"Psychiatric Services"},{"issue":"3","key":"10.1016\/j.jsat.2019.10.001_bb0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1542\/peds.111.3.564","article-title":"Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: The adverse childhood experiences study","volume":"111","author":"Dube","year":"2003","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.jsat.2019.10.001_bb0040","first-page":"1","article-title":"Practice guideline for the treatment of patients with major depressive disorder third edition","volume":"167","author":"Gelenberg","year":"2010","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2019.10.001_bb0045","series-title":"U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Drug overdose deaths in the United States, 1999\u20132016","first-page":"1","author":"Hedegaard","year":"2017"},{"issue":"3","key":"10.1016\/j.jsat.2019.10.001_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2105\/AJPH.2015.302982","article-title":"Recurring epidemics of pharmaceutical drug abuse in America: Time for an all-drug strategy","volume":"106","author":"Herzberg","year":"2016","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2019.10.001_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.29.020907.090847","article-title":"The descriptive epidemiology of commonly occurring mental disorders in the United States","volume":"29","author":"Kessler","year":"2008","journal-title":"Annual Review of Public Health"},{"issue":"4 Suppl","key":"10.1016\/j.jsat.2019.10.001_bb0060","first-page":"5","article-title":"Treatment of patients with substance use disorders, American Psychiatric Association","volume":"164","author":"Kleber","year":"2007","journal-title":"The American journal of psychiatry"},{"issue":"9","key":"10.1016\/j.jsat.2019.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11606-016-3740-0","article-title":"Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care","volume":"31","author":"Kroll","year":"2016","journal-title":"Journal of General Internal Medicine"},{"issue":"8","key":"10.1016\/j.jsat.2019.10.001_bb0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2019.10.001_bb0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2017.05.016","article-title":"High enhancer, downer, withdrawal helper: Multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City","volume":"46","author":"Mateu-Gelabert","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.jsat.2019.10.001_bb9015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/HRP.0000000000000058","article-title":"Treatment of co-occurring anxiety disorders and substance use disorders","volume":"23","author":"McHugh","year":"2015","journal-title":"Harvard review of psychiatry"},{"key":"10.1016\/j.jsat.2019.10.001_bb0085","series-title":"The ASAM principles of addiction medicine","year":"2019"},{"key":"10.1016\/j.jsat.2019.10.001_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.drugpo.2017.07.012","article-title":"\u201cI love having benzos after my coke shot\u201d: The use of psychotropic medication among cocaine users in downtown Montreal","volume":"49","author":"Motta-Ochoa","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2019.10.001_bb0100","series-title":"Multiple Cause of Death 1999-2017 on CDC Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER)","year":"2018"},{"key":"10.1016\/j.jsat.2019.10.001_bb0105","first-page":"223","article-title":"Prescribing of benzodiazepines and opioids to individuals with substance use disorders. Drug and alcohol dependence","volume":"178","author":"O\u2019Brien","year":"2017"},{"issue":"2","key":"10.1016\/j.jsat.2019.10.001_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.jsat.2019.10.001_bb9000","first-page":"1","article-title":"Controlled substance prescribing patterns\u2014prescription behavior surveillance system, eight states, 2013","volume":"64","author":"Paulozzi","year":"2015","journal-title":"Morbidity and Mortality Weekly Report: Surveillance Summaries"},{"issue":"6","key":"10.1016\/j.jsat.2019.10.001_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.genhosppsych.2015.06.004","article-title":"Demographic and clinical factors associated with benzodiazepine prescription at discharge from psychiatric inpatient treatment","volume":"37","author":"Peters","year":"2015","journal-title":"General Hospital Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2019.10.001_bb0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2007.64","article-title":"Trends in opioid prescribing by race\/ethnicity for patients seeking care in US emergency departments","volume":"299","author":"Pletcher","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2019.10.001_bb0125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jsat.2015.09.006","article-title":"Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: An integrative literature review","volume":"61","author":"Priester","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2019.10.001_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.drugalcdep.2016.09.021","article-title":"The relationships of childhood trauma and adulthood prescription pain reliever misuse and injection drug use","volume":"169","author":"Quinn","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2019.10.001_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13063-015-0715-0","article-title":"Person-centered care planning and service engagement: A study protocol for a randomized controlled trial","volume":"16","author":"Stanhope","year":"2015","journal-title":"Trials"},{"key":"10.1016\/j.jsat.2019.10.001_bb0145","series-title":"The American Society of Addiction Medicine handbook of addiction medicine","first-page":"437","article-title":"Psychiatric co-occurring disorders","author":"Stoller","year":"2016"},{"issue":"1","key":"10.1016\/j.jsat.2019.10.001_bb0150","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: A systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:03:53Z","timestamp":1778540633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219301291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":30,"alternative-id":["S0740547219301291"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.10.001","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with benzodiazepine prescribing in community mental health settings","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}